Background Although the coronavirus disease 2019 (COVID-19) pandemic continues to rage worldwide, clinical and laboratory studies of this disease have been limited in many countries. We investigated the epidemiologic, clinical, and laboratory findings of COVID-19 infected patients to identify the effective indicators correlated with the disease. Methods A retrospective study was conducted at King Abdullah Hospital in Bisha Province, Saudi Arabia, from March 20 to June 30, 2020. Patients of different age groups were confirmed as having COVID-19 infection using a real-time polymerase chain reaction. The demographic, clinical, and laboratory data of the patients were statistically analyzed. Results Of the 132 patients, 85 were male and 47 were female, with a mean age of 50.9 years (SD±16.7). The patients were elderly (n = 29) and adults (n = 103). Of these, 54 (40.9%) had comorbidities, (25%) were admitted to the intensive care unit (ICU), and 12 (9.1%) died. On admission, the main clinical manifestations were fever (84.1%), cough (64.4%), shortness of breath (25%), chest pain (20.5%), and fatigue (18.2%). In all patients, increased neutrophils and decreased lymphocytes were observed. Patients’ lactate dehydrogenase (LDH) was elevated. C-reactive protein (CRP) was elevated in 48.5%, D-dimer in 43.2%, and the erythrocyte sedimentation rate (ESR) in 40.9% of patients. The elderly showed higher neutrophil (p = 0.011) and lower lymphocyte (p = 0.009) counts than adults. Glucose, creatine kinase-MB, LDH, bilirubin, D-dimer, and ESR were significantly higher in the elderly than in the adults. The COVID-19 death group had a higher leucocyte count (p = 0.036), and higher urea (p = 0.029) and potassium (p = 0.022) than the recovered group but had a lower hemoglobin concentration (p = 0.018). A significant association was determined between COVID-19 death and the presence of cardiovascular disease (χ2(1) = 16.297, p<0.001), hypertension (χ2(1) = 12.034, p = 0.001), renal failure (χ2(1) = 3.843, p = 0. 05), old age (t (130) = 4.9, p <0.001), and ICU admission (χ2(1) = 17.6 (1), p<0.001). Conclusions Investigating some of the laboratory and clinical parameters could help assess the disease progression, risk of mortality, and follow up patients who could progress to a fatal condition.
【초록키워드】 COVID-19, coronavirus disease, pandemic, Mortality, intensive care, fatigue, neutrophil, Comorbidities, LDH, risk, cardiovascular disease, D-dimer, progression, cough, hypertension, lactate dehydrogenase, Saudi Arabia, ICU, Laboratory, Retrospective study, lymphocyte, Adults, COVID-19 infection, Fever, male, female, Patient, ICU admission, death, age, ESR, Potassium, hemoglobin, group, disease, Admission, patients, association, Creatine kinase-MB, Concentration, Bilirubin, chest pain, leucocyte, urea, C-reactive protein (CRP, clinical manifestation, Shortness of breath, erythrocyte sedimentation rate, laboratory data, help, renal, death group, clinical parameter, effective, polymerase chain, Result, analyzed, identify, died, the patient, investigated, the disease, elevated, conducted, was determined, correlated, significantly higher, statistically, COVID-19 infected patient, King, 【제목키워드】 COVID-19, coronavirus disease, hospital, Saudi Arabia, Laboratory, Patient, age, group,